The Pharmacokinetics of Levosalbutamol: What are the Clinical Implications?

Author： Boulton D.W.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.40, Iss.1, 2001-01, pp. : 23-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Over-the-Counter Triptans for Migraine: What are the Implications?

By Tfelt-Hansen Peer  

CNS Drugs, Vol. 21, Iss. 11, 2007-01 ,pp. : 877-883

Adis International

Access to resources Recommend Favorite

The New ABPI Code of Practice: What Are the Key Changes and Their Implications?

By Barnard Joan  

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 4, 2006-01 ,pp. : 221-225

Adis International

Access to resources Recommend Favorite

The Internet and Drug Safety: What are the Implications for Pharmacovigilance?

By Cobert B.  

Drug Safety, Vol. 20, Iss. 2, 1999-02 ,pp. : 95-107

Adis International

Access to resources Recommend Favorite

Proton Pump Inhibitors: Do Differences in Pharmacokinetics Translate into Differences in Clinical Outcomes?

By Kwong Ming Fock  

Clinical Pharmacokinetics, Vol. 47, Iss. 1, 2008-01 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics in the 21st Century: Does the Evidence Support Definitive Outcomes?

By Ensom H.  

Clinical Pharmacokinetics, Vol. 34, Iss. 4, 1998-04 ,pp. : 265-279

Adis International

Access to resources Recommend Favorite